Health Care & Life Sciences » Biotechnology | Tissue Regenix Group PLC

Tissue Regenix Group PLC

Tissue Regenix Group PLC
Stock Exchange London Stock Exchange
Market Cap
GBP38.61 M
Shares Outstanding
1.17 B
Public Float
981.64 M


Astley Lane Industrial Estate
Leeds Yorkshire LS26 8XT
United Kingdom
Employees -
Updated 07/08/2019
Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. Its patented decellularisation technology removes DNA and other cellular material from animal and human tissue leaving a cellular tissue scaffold, which is not rejected by the patient's body which can then be used to repair diseased and worn out body parts. The potential applications of this process address clinical needs such as vascular disease, heart valve replacement and knee repair.


View All

John Andrew Walter Samuel
Executive Chairman
Steven Ashley Couldwell
Chief Executive Officer & Non-Executive Director